Alzheimer drugs show promise, but Poland still lacks funding

Drugs that slow Alzheimer's progression now exist, yet Poland does not fund them, and many patients receive a diagnosis too late to benefit. Experts released a report showing care costs are rising while families bear the main burden of organizing treatment. The report outlines systemic changes needed for Poland's healthcare system to catch up with medical advances.